MediPharm Labs (LABS) Competitors C$0.09 0.00 (0.00%) As of 04/25/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. RX, CRDL, HLS, TGOD, NINE, SUGR, WMD, MDP, HEXO, and VIRShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include BioSyent (RX), Cardiol Therapeutics (CRDL), HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), SugarBud Craft Growers (SUGR), WeedMD (WMD), Medexus Pharmaceuticals (MDP), HEXO (HEXO), and Viridium Pacific Group (VIR). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. BioSyent Cardiol Therapeutics HLS Therapeutics Green Organic Dutchman Delta 9 Cannabis SugarBud Craft Growers WeedMD Medexus Pharmaceuticals HEXO Viridium Pacific Group MediPharm Labs (TSE:LABS) and BioSyent (CVE:RX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, community ranking, risk, earnings and dividends. Does the MarketBeat Community believe in LABS or RX? BioSyent received 69 more outperform votes than MediPharm Labs when rated by MarketBeat users. Likewise, 66.20% of users gave BioSyent an outperform vote while only 65.79% of users gave MediPharm Labs an outperform vote. CompanyUnderperformOutperformMediPharm LabsOutperform Votes2565.79% Underperform Votes1334.21% BioSyentOutperform Votes9466.20% Underperform Votes4833.80% Which has more risk and volatility, LABS or RX? MediPharm Labs has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, BioSyent has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Is LABS or RX more profitable? BioSyent has a net margin of 20.60% compared to MediPharm Labs' net margin of -30.56%. BioSyent's return on equity of 20.01% beat MediPharm Labs' return on equity.Company Net Margins Return on Equity Return on Assets MediPharm Labs-30.56% -24.41% -7.17% BioSyent 20.60%20.01%12.86% Do insiders & institutionals believe in LABS or RX? 0.7% of MediPharm Labs shares are owned by institutional investors. Comparatively, 1.4% of BioSyent shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Comparatively, 33.7% of BioSyent shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor LABS or RX? In the previous week, BioSyent had 1 more articles in the media than MediPharm Labs. MarketBeat recorded 1 mentions for BioSyent and 0 mentions for MediPharm Labs. BioSyent's average media sentiment score of 1.05 beat MediPharm Labs' score of 0.00 indicating that BioSyent is being referred to more favorably in the news media. Company Overall Sentiment MediPharm Labs Neutral BioSyent Positive Which has stronger valuation & earnings, LABS or RX? BioSyent has lower revenue, but higher earnings than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than BioSyent, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediPharm LabsC$39.42M0.95-C$12.05M-C$0.03-3.10BioSyentC$34.06M3.53C$7.02MC$0.6217.04 SummaryBioSyent beats MediPharm Labs on 14 of the 15 factors compared between the two stocks. Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$37.35MC$2.17BC$5.47BC$5.66BDividend YieldN/A2.92%5.43%6.45%P/E Ratio-3.104.3122.3929.08Price / Sales0.95499.23391.43569.46Price / Cash1.3010.2538.1883.35Price / Book0.826.386.683.75Net Income-C$12.05MC$20.70BC$3.22BC$301.40M7 Day PerformanceN/A2.74%6.25%2.44%1 Month PerformanceN/A0.28%-2.70%-1.53%1 Year PerformanceN/A94.32%16.86%12.48% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.09flatN/A+12.5%C$37.35MC$39.42M-3.10130RXBioSyentN/AC$10.50+2.3%N/A+23.4%C$120.09MC$34.06M17.04N/ANews CoverageGap UpCRDLCardiol TherapeuticsN/AC$1.33+0.8%N/A-39.2%C$110.36MN/A-2.6120Gap UpHLSHLS Therapeutics0.5156 of 5 starsC$4.38+3.1%C$4.50+2.7%-9.0%C$97.45MC$40.13M-4.3991Gap UpTGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Positive NewsGap UpSUGRSugarBud Craft GrowersN/AC$12.25-2.0%N/A+11,036.4%C$83.55MC$575.64M14.7644Gap UpWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpMDPMedexus Pharmaceuticals1.5241 of 5 starsC$2.53+0.4%C$5.49+116.9%+40.6%C$56.64MC$100.25M12.1098Positive NewsHEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up Related Companies and Tools Related Companies BioSyent Competitors Cardiol Therapeutics Competitors HLS Therapeutics Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors SugarBud Craft Growers Competitors WeedMD Competitors Medexus Pharmaceuticals Competitors HEXO Competitors Viridium Pacific Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
